作者: sorbitol 時(shí)間: 2025-3-21 20:17 作者: Foreshadow 時(shí)間: 2025-3-22 02:01
Hiroaki ShimokawaReviews the latest findings on epicardial coronary spasm and coronary microvascular dysfunction.Presents a range of experimental and clinical studies.Chiefly intended for practicing cardiologists, car作者: Culmination 時(shí)間: 2025-3-22 07:28
http://image.papertrans.cn/c/image/238342.jpg作者: Congestion 時(shí)間: 2025-3-22 10:35 作者: justify 時(shí)間: 2025-3-22 14:18
Neural Repair with Pluripotent Stem Cells belongs to the family of serine/threonine kinases and is an important downstream effector of the small GTP-binding protein RhoA. Two isoforms of Rho-kinase, ROCK1 and ROCK2, have different functions with ROCK1 for circulating inflammatory cells and ROCK2 for vascular smooth muscle cells. The RhoA/R作者: justify 時(shí)間: 2025-3-22 19:49 作者: 精美食品 時(shí)間: 2025-3-23 01:02 作者: vocation 時(shí)間: 2025-3-23 04:52 作者: craven 時(shí)間: 2025-3-23 08:12
The 4-cusp Approach to Cancer Carebe heterogeneous, including several structural and functional alterations. Among them, central to coronary vasomotion abnormalities are threefold: enhanced coronary vasoconstrictive reactivity (i.e. coronary spasm) at epicardial and microvascular levels, reduced endothelium-dependent and -independen作者: overwrought 時(shí)間: 2025-3-23 10:39
The 4-cusp Approach to Cancer Careease (CAD) and epicardial coronary artery spasm. Since several studies indicated that CMD could be associated with increased risk of cardiovascular events, it is important to make correct diagnosis and assessment of CMD. However, in contrast with epicardial coronary arteries, the coronary microcircu作者: 扔掉掐死你 時(shí)間: 2025-3-23 16:03
Spiritual Approaches to Living with Canceradverse cardiac events. Nevertheless, the management of CMD represents a major unmet need because the lack of large, randomized studies makes it difficult to generate evidence-based recommendations. Recently, it was demonstrated that stratified medical therapy guided by an interventional diagnostic 作者: 錫箔紙 時(shí)間: 2025-3-23 18:15 作者: 嘲笑 時(shí)間: 2025-3-24 00:31 作者: cornucopia 時(shí)間: 2025-3-24 05:07 作者: Metastasis 時(shí)間: 2025-3-24 09:48 作者: 口音在加重 時(shí)間: 2025-3-24 13:42 作者: 禍害隱伏 時(shí)間: 2025-3-24 16:48
Epidemiology of Vasospastic Anginay artery spasm. The term of VSA is basically synonymous with the terms Prinzmetal’s angina and variant angina, and is known to be associated with a wide variety of cardiac ischemic conditions, including stable angina, acute coronary syndrome, and life-threatening arrhythmic events. A number of studi作者: thrombus 時(shí)間: 2025-3-24 20:34 作者: negotiable 時(shí)間: 2025-3-25 00:44 作者: Esophagus 時(shí)間: 2025-3-25 06:24
Treatment of Coronary Artery Spasmrome and sudden cardiac death in Asia and Western countries. In the era of widespread utilization of drug-eluting stents (DES) in the field of coronary intervention, it is important to realize the fact that patients still have unremitting angina symptoms even after resolving organic coronary stenosi作者: MOTTO 時(shí)間: 2025-3-25 08:38
Epidemiology of Coronary Microvascular Dysfunctionrdiovascular disease. Several invasive and non-invasive assessments are available for a comprehensive evaluation of the underlying microvascular abnormalities (e.g. coronary flow velocity reserve (CFR) via transthoracic Doppler echocardiography, cardiac magnetic resonance imaging or positron emissio作者: 不可磨滅 時(shí)間: 2025-3-25 15:17
Pathophysiology of Coronary Microvascular Dysfunctionbe heterogeneous, including several structural and functional alterations. Among them, central to coronary vasomotion abnormalities are threefold: enhanced coronary vasoconstrictive reactivity (i.e. coronary spasm) at epicardial and microvascular levels, reduced endothelium-dependent and -independen作者: 他日關(guān)稅重重 時(shí)間: 2025-3-25 17:29 作者: 倒轉(zhuǎn) 時(shí)間: 2025-3-26 00:01
Treatment of Coronary Microvascular Dysfunctionadverse cardiac events. Nevertheless, the management of CMD represents a major unmet need because the lack of large, randomized studies makes it difficult to generate evidence-based recommendations. Recently, it was demonstrated that stratified medical therapy guided by an interventional diagnostic 作者: Substitution 時(shí)間: 2025-3-26 00:08
H. Paul Ehrlich,Kurtis E. Moyereactive protein, and remnant lipoprotein are significant risk factors for coronary spasm. Recently, the Japanese Coronary Spasm Association (JCSA) demonstrated that, in the temporary VSA patients, overall 5-year survival rate free from all-cause death or major adverse cardiac events was 98% and 91%,作者: 招惹 時(shí)間: 2025-3-26 06:24
Neural Repair with Pluripotent Stem Cellsasudil, a selective Rho-kinase inhibitor, have been demonstrated for the treatment of several cardiovascular diseases in animals and humans. Thus, the Rho-kinase pathway is an important new therapeutic target in vasospasm and other cardiovascular diseases.作者: 忙碌 時(shí)間: 2025-3-26 11:57
The 4-cusp Approach to Cancer Careof future cardiovascular events in patients with VSA. Ample clinical evidence has been accumulated for elucidating the detailed mechanisms of coronary artery spasm in vivo. In this chapter, we will summarize recent advances in diagnostic methodology of coronary artery spasm.作者: Instrumental 時(shí)間: 2025-3-26 13:32 作者: 強(qiáng)壯 時(shí)間: 2025-3-26 17:31 作者: 脫毛 時(shí)間: 2025-3-26 22:25 作者: Contend 時(shí)間: 2025-3-27 02:13 作者: Hirsutism 時(shí)間: 2025-3-27 06:25 作者: 傾聽 時(shí)間: 2025-3-27 11:31
Epidemiology of Vasospastic Anginaeactive protein, and remnant lipoprotein are significant risk factors for coronary spasm. Recently, the Japanese Coronary Spasm Association (JCSA) demonstrated that, in the temporary VSA patients, overall 5-year survival rate free from all-cause death or major adverse cardiac events was 98% and 91%,作者: BIDE 時(shí)間: 2025-3-27 17:16
Pathophysiology and Molecular Mechanisms of Coronary Artery Spasmasudil, a selective Rho-kinase inhibitor, have been demonstrated for the treatment of several cardiovascular diseases in animals and humans. Thus, the Rho-kinase pathway is an important new therapeutic target in vasospasm and other cardiovascular diseases.作者: 存在主義 時(shí)間: 2025-3-27 20:13
Diagnosis of Coronary Artery Spasmof future cardiovascular events in patients with VSA. Ample clinical evidence has been accumulated for elucidating the detailed mechanisms of coronary artery spasm in vivo. In this chapter, we will summarize recent advances in diagnostic methodology of coronary artery spasm.作者: DIKE 時(shí)間: 2025-3-28 01:37 作者: 沉積物 時(shí)間: 2025-3-28 03:02 作者: lymphedema 時(shí)間: 2025-3-28 06:50 作者: harbinger 時(shí)間: 2025-3-28 13:26 作者: 懶惰人民 時(shí)間: 2025-3-28 15:12 作者: BUST 時(shí)間: 2025-3-28 19:32
Book 19994th editiontionen zu den neuesten Phytotherapeutika und ist gleichzeitig eine kompetente Einführung in die Prinzipien der rationalen Therapie mit Arzneidrogen. Dieses Buch darf in keiner Praxis und Apotheke fehlen.作者: grovel 時(shí)間: 2025-3-29 00:05
